Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 May 2020
Historique:
received: 24 07 2019
entrez: 28 5 2020
pubmed: 28 5 2020
medline: 7 2 2021
Statut: epublish

Résumé

ABSTRACT<br />Large Tumor Suppressor (LATS2) gene are Tumor Suppressor gene, linked with epigenetic modifications. LATS2 promoter hypermethylation is an important epigenetic silencing mechanism leading to cancer. Cancer is the most common, vicious and dangerously increasing diseases of the world today, associated with high morbidity and mortality. Oral cancers (OC) are the blazing universal dilemma and is the sixth most frequent cancer observed in Indian population. Tobacco consumption is the main cause of the increase in OSCC. The association between LATS2 in the pathogenesis of cancers propose that their combination might be studied as a possible molecular marker for particular subgroups of patients. Therefore, the present study tried to investigate whether LATS2 promoter methylation was associated with oral squamous cell carcinoma (OSCC) in North Indian subjects. DNA methylation quantitative studies of LATS2 Tumor Suppressor genes were performed by methylation-specific polymerase chain reaction (MSP). 38 out of 70 patients (55 %) were found to be methylated for LATS2 gene, a statistically significant result was obtained (p-value < 0.005) for LATS2 genes. The results suggest that epigenetic changes may be related to the down-regulation of LATS2 expression. It can be concluded that LATS2 gene plays a significant role in the diagnosis of cancer and provide a better alternative as a diagnostic biomarker. Our data infer that a low LATS2 expression due to methylation may contribute to the cancer progression and could be useful for the diagnosis of OSCC. Therefore, investigation of promoter methylation in such genes may provide a biomarker which may prove to be useful in early detection of Oral Cancer.<br />Keywords: Oral squamous cell carcinoma (OSCC), Epigenetic changes, LATS2 gene, Promoter Hypermethylation, Methylation-Specific PCR (MSP), Biomarkers<br />Abbreviations: OSCC- Oral Squamous Cell Carcinoma; DNA- Deoxyribonucleic acid; LATS-Large Tumor Suppressor (gene); MSP-Methylation-Specific Polymerase Chain Reaction.

Identifiants

pubmed: 32458634
doi: 10.31557/APJCP.2020.21.5.1283
pmc: PMC7541850
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
Tumor Suppressor Proteins 0
LATS2 protein, human EC 2.7.1.11
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1283-1287

Références

Cell Death Differ. 2013 Oct;20(10):1287-8
pubmed: 24013777
J Cell Sci. 2011 Jan 1;124(Pt 1):57-67
pubmed: 21118956
J Ophthalmol. 2016;2016:5431021
pubmed: 26942001
J Cell Sci. 2013 Oct 1;126(Pt 19):4358-68
pubmed: 23886938
Clin Epigenetics. 2011 Nov 01;3:6
pubmed: 22414247
Oncol Lett. 2010 Mar;1(2):303-307
pubmed: 22966299
Neurosci Res. 2006 Dec;56(4):450-8
pubmed: 17049657
Tumour Biol. 2016 Feb;37(2):1715-25
pubmed: 26314854
Oncogene. 2003 Jul 10;22(28):4398-405
pubmed: 12853976
Oncol Rep. 2009 Dec;22(6):1277-82
pubmed: 19885577
Int J Cancer. 2001 Oct 15;94(2):153-6
pubmed: 11668491
Clin Cancer Res. 2005 Feb 15;11(4):1380-5
pubmed: 15746036
Oncogene. 2002 Feb 14;21(8):1233-41
pubmed: 11850843
World J Gastroenterol. 2013 Jul 21;19(27):4363-73
pubmed: 23885148
J Dent Res. 2008 Jan;87(1):14-32
pubmed: 18096889
PLoS One. 2013 Apr 04;8(4):e60283
pubmed: 23593187
Arch Oral Biol. 2010 Oct;55(10):809-14
pubmed: 20674887
Biochem Genet. 2012 Jun;50(5-6):448-53
pubmed: 22212460
Int J Biol Markers. 2010 Apr-Jun;25(2):99-103
pubmed: 20586029
Med Oral Patol Oral Cir Bucal. 2014 Nov 01;19(6):e562-8
pubmed: 25129245
Genes (Basel). 2014 Sep 16;5(3):821-64
pubmed: 25229548
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Br J Biomed Sci. 2014;71(3):100-3
pubmed: 25265753
Mol Biol Int. 2012;2012:141732
pubmed: 22577550

Auteurs

Harsh Goel (H)

Department of Biotechnology, Institute of Applied Medicines and Research Ghaziabad, Uttar Pradesh, India.

Saloni Singhal (S)

Department of Biotechnology, Institute of Applied Medicines and Research Ghaziabad, Uttar Pradesh, India.

Runjhun Mathur (R)

Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India.

Saima Syeda (S)

Department of Zoology, Delhi University, India.

Rishi Kumar Gupta (RK)

Sh. Jagannath Charitable Cancer Hospital, Ghaziabad, Uttar Pradesh, India.

Anshuman Kumar (A)

Dharamshila Cancer Hospital and Research Centre, New Delhi, India.

Anju Shrivastava (A)

Department of Zoology, Delhi University, India.

Abhimanyu Kumar Jha (AK)

Department of Biotechnology, Institute of Applied Medicines and Research Ghaziabad, Uttar Pradesh, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH